Overview

This trial is active, not recruiting.

Condition cocaine-related disorders
Treatment cocaine (iv)
Phase phase 1
Sponsor National Institute on Drug Abuse (NIDA)
Start date September 2004
End date July 2005
Trial size 16 participants
Trial identifier NCT00094315, NIDA-CTO-0014-1

Summary

To study of classical conditioning mechanisms associated with arousal, craving and cocaine use.

United States No locations recruiting
Other Countries No locations recruiting

Primary Outcomes

Measure
Stimulated and non-stimulated craving
time frame:
Cocaine assessment
time frame:

Eligibility Criteria

Male or female participants from 18 years up to 55 years old.

Inclusion Criteria: - Be English-speaking volunteers who are cocaine dependent - Be non-treatment seeking at the time of the study - Meet DSM-IV criteria for cocaine dependence - Have ECG showing normal sinus rhythm, normal conductivity, and non clinically significant arrhythmias - Females must provide a negative pregnancy test and agree to use birth control - Have baseline laboratory tests within normal limits Exclusion Criteria: - Please contact site for more information

Additional Information

Official title Cocaine Relapse Prevention II
Principal investigator John Roache, Ph.D.
Description This is a single-site, double-blind, placebo-controlled crossover study of classical conditioning mechanisms associated with arousal, craving and cocaine use.
Trial information was received from ClinicalTrials.gov and was last updated in October 2007.
Information provided to ClinicalTrials.gov by National Institute on Drug Abuse (NIDA).